Tenet Healthcare Corporation

NYSE:THC Rapport sur les actions

Capitalisation boursière : US$14.6b

Tenet Healthcare Gestion

Gestion contrôle des critères 2/4

Le PDG Tenet Healthcare est Saum Sutaria, nommé en Sep2021, a un mandat de 3.17 ans. La rémunération annuelle totale est $ 18.52M, composée du salaire de 8.1% et des bonus 91.9%, y compris les actions et options de la société. détient directement 0.29% des actions de la société, d'une valeur de $ 41.64M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.7 ans et 6.5 ans.

Informations clés

Saum Sutaria

Directeur général

US$18.5m

Rémunération totale

Pourcentage du salaire du PDG8.1%
Durée du mandat du directeur général3.2yrs
Propriété du PDG0.3%
Durée moyenne d'occupation des postes de direction3.7yrs
Durée moyenne du mandat des membres du conseil d'administration6.5yrs

Mises à jour récentes de la gestion

Recent updates

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Nov 17
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services

Nov 04

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Oct 30
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Tenet Healthcare: Becoming A Very Healthy Business

Sep 09

Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price

Sep 06
Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price

Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade)

Aug 29

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Aug 13
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Jul 11
An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)

Jun 17

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

May 21
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Apr 30
Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Mar 18
Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Tenet Healthcare: Shrinking To Grow

Feb 04

Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

Dec 18
Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Nov 15
We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt

Oct 13

Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Aug 02
Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now

Jul 28

Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

Apr 13
Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

USPI and Providence extend hands to aid ambulatory surgical services

Feb 09

Analyse de la rémunération des PDG

Comment la rémunération de Saum Sutaria a-t-elle évolué par rapport aux bénéfices de Tenet Healthcare?
DateRémunération totaleSalaireBénéfices de l'entreprise
Sep 30 2024n/an/a

US$3b

Jun 30 2024n/an/a

US$3b

Mar 31 2024n/an/a

US$3b

Dec 31 2023US$19mUS$2m

US$611m

Sep 30 2023n/an/a

US$469m

Jun 30 2023n/an/a

US$499m

Mar 31 2023n/an/a

US$414m

Dec 31 2022US$11mUS$1m

US$410m

Sep 30 2022n/an/a

US$558m

Jun 30 2022n/an/a

US$875m

Mar 31 2022n/an/a

US$957m

Dec 31 2021US$21mUS$1m

US$915m

Sep 30 2021n/an/a

US$1b

Jun 30 2021n/an/a

US$434m

Mar 31 2021n/an/a

US$402m

Dec 31 2020US$9mUS$1m

US$399m

Sep 30 2020n/an/a

-US$18m

Jun 30 2020n/an/a

-US$48m

Mar 31 2020n/an/a

-US$112m

Dec 31 2019US$14mUS$962k

-US$226m

Rémunération vs marché: La rémunération totale de Saum ($USD 18.52M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 12.73M ).

Rémunération et revenus: La rémunération de Saum a augmenté de plus de 20 % au cours de l'année écoulée.


PDG

Saum Sutaria (51 yo)

3.2yrs

Titularisation

US$18,518,110

Compensation

Dr. Saumya Sutaria, M.D., also known as Saum, serves as Member of Advisory Board at Vida Health, Inc. Dr. Sutaria served as Chief Operating Officer at Tenet Healthcare Corp. since January 06, 2019 until S...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Saumya Sutaria
Chairman & CEO3.2yrsUS$18.52m0.29%
$ 41.6m
Paola Arbour
Executive VP & Chief Information Officer6.5yrsUS$2.47m0.023%
$ 3.3m
Thomas Arnst
EVP, Chief Administrative Officer3.7yrsUS$3.67mpas de données
Lisa Foo
Executive Vice President of Commercial Operations2.7yrsUS$3.24m0.016%
$ 2.4m
Sun Park
Executive VP & CFOless than a yearpas de donnéespas de données
William McDowell
Vice President of Investor Relationsno datapas de donnéespas de données
Jana Durfee
Senior VP & Chief Compliance Officerno datapas de donnéespas de données
Michael Maloney
Executive Vice President of Corporate Development7.8yrspas de donnéespas de données
Clint Hailey
Chief Managed Care Officer & Senior VP17.3yrspas de donnéespas de données
Liz Johnson
Chief Applied Clinical Informatics Officerno datapas de donnéespas de données
Andrew Johnston
Chief Administrative Officer - USPI1.8yrspas de donnéespas de données
Ernest Franklin
Senior Vice President & Chief Clinical Operations Officer5.8yrspas de donnéespas de données

3.7yrs

Durée moyenne de l'emploi

55yo

Âge moyen

Gestion expérimentée: L'équipe de direction de THC est considérée comme expérimentée (ancienneté moyenne 3.7 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Saumya Sutaria
Chairman & CEO4yrsUS$18.52m0.29%
$ 41.6m
James Bierman
Independent Director7.1yrsUS$333.54k0.040%
$ 5.8m
Stephen Rusckowski
Independent Director1.5yrsUS$238.93k0%
$ 0
Meghan FitzGerald
Independent Director6.5yrsUS$339.04k0.0081%
$ 1.2m
Joseph Kerrey
Lead Independent Director23.7yrsUS$541.53k0.024%
$ 3.5m
Richard Mark
Independent Director7yrsUS$335.04k0.018%
$ 2.6m
Richard Fisher
Independent Director7yrsUS$351.04k0.0070%
$ 1.0m
Tammy Romo
Independent Director9.7yrsUS$356.04k0.051%
$ 7.4m
Christopher Lynch
Independent Director5.3yrsUS$331.04k0.00029%
$ 42.3k
Mark Kopser
Executive Chairman of Aspen Healthcare no datapas de donnéespas de données
Cecil Haney
Independent Director3.8yrsUS$327.04k0.0018%
$ 258.1k
Nadja West
Independent Director5.1yrsUS$320.04k0.021%
$ 3.0m

6.5yrs

Durée moyenne de l'emploi

67yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de THC sont considérés comme expérimentés (ancienneté moyenne 6.5 ans).